Boothbay Fund Management, LLC Ovid Therapeutics Inc. Transaction History

Boothbay Fund Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.69 - $3.31 $120,816 - $236,628	-71,489 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.13 - $3.73 $126,937 - $151,270	-40,555 Reduced 36.2%	71,489 $229,000
Q3 2021 Nov 15, 2021	SELL	$3.31 - $4.04 $97,277 - $118,731	-29,389 Reduced 20.78%	112,044 $376,000
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $31,676 - $43,099	9,599 Added 7.28%	141,433 $553,000
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $319,038 - $589,297	131,834 New	131,834 $530,000

Q2 2020 Aug 14, 2020	SELL	$2.67 - $7.91 $155,842 - $461,690	-58,368 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.03 - $4.35 $35,261 - $75,559	-17,370 Reduced 22.93%	58,368 $174,000
Q4 2019 Feb 14, 2020	SELL	$2.08 - $5.06 $7,606 - $18,504	-3,657 Reduced 4.61%	75,738 $314,000
Q3 2019 Nov 14, 2019	BUY	$1.76 - $3.51 $139,735 - $278,676	79,395 New	79,395 $257,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $54.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.